StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NUS$5.63-2.76%
Fair $5.63+0.0%

NUS

Nu Skin Enterprises, Inc.

Consumer Defensive / Household & Personal ProductsNYSE

$5.63

-0.16 (-2.76%)

Fairly Valued+0.0%Fair Value $5.63Fund rank 33/100 · Data gapFallback financials|
SA 40/C
F-Score: 6/9
Declining Revenue

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $60.1M · quality 72.3/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 63/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 18Warnings: 1unknown: 18
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 4 consecutive years
Thesis & Journal · NUSLocal privado en este navegador · Nu Skin Enterprises, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$273M

P/E

5.2x

↓

EV/EBITDA

1.3x

↓

ROE

19.9%

↑

Gross Margin

69.4%

↑

Debt/Equity

0.38

↑
52-Week Range$6
$6$15

TradingView lightweight chart

NUS price, volumen y niveles de valoración

Último $5.630Periodo -38.3%
Fair value: $5.630

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2008–2025 · 17 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

-3.7%

FCF margin

3.1%

FCF / Net income

0.29x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.49B · net income $160.2M · FCF $46.0M

2008-FY → 2025-FY

Gross margin

69.4%— pts

Operating margin

6.1%— pts

Net margin

10.8%— pts

FCF margin

3.1%— pts
MetricTTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Income Statement
Revenue$1.49B$1.49B$1.73B$1.97B$2.23B$2.70B$2.58B$2.42B$2.68B$2.28B$2.21B$2.25B$2.57B$3.18B$2.13B$1.72B$1.54B$1.33B—
Net Income$160.2M$160.2M$-146.6M$8.6M$104.8M$147.3M$191.4M$173.6M$121.9M$129.4M$143.1M$133.0M$189.2M$364.9M$221.6M$153.3M$136.1M$89.8M$65.3M
EBITDA$262.4M$262.4M$-78.8M$123.1M$175.0M$310.3M$331.6M$344.1M$323.9M$346.0M$303.5M$316.1M$407.1M$589.0M$374.3M$266.6M$246.7M$176.3M$155.8M
EPS3.183.18-2.950.172.072.863.633.102.162.362.552.253.115.943.522.382.111.401.02
Gross Margin69.4%69.4%68.2%68.9%71.7%75.0%74.5%76.0%76.3%78.0%77.3%78.2%81.4%84.1%83.4%81.2%82.3%81.7%—
Operating Margin6.1%6.1%2.9%3.5%7.2%8.7%10.0%11.0%9.0%12.0%10.5%10.9%13.7%17.4%16.0%13.6%14.1%11.1%—
Net Margin10.8%10.8%-8.5%0.4%4.7%5.5%7.4%7.2%4.5%5.7%6.5%5.9%7.4%11.5%10.4%8.9%8.9%6.7%—
Balance Sheet
Debt/Equity0.380.380.730.740.580.290.340.380.460.440.500.220.170.130.260.190.280.32—
Current Ratio2.042.04—————————————————
Cash Flow
Free Cash Flow$46.0M$46.0M$70.2M$60.1M$49.0M$73.0M$315.3M$111.9M$132.4M$242.4M$225.0M$265.5M—$345.1M$214.3M$182.5M$134.1M$113.7M$87.3M
Returns
ROE19.9%19.9%-22.5%1.0%11.7%16.1%21.4%19.8%15.6%18.4%21.5%16.1%20.1%42.5%37.5%26.7%28.9%23.9%20.7%
Valuation
P/E5.215.21—109.5920.91——————————————
EV/EBITDA1.341.34—10.4013.96——————————————
P/B0.350.350.571.132.44——————————————
Growth & Yield
Revenue Growth-14.3%-14.3%-12.0%-11.5%—4.4%6.7%-9.7%17.5%3.2%-1.7%-12.5%-19.1%49.0%24.0%11.9%15.5%——
EPS Growth207.8%207.8%-1835.3%-91.8%—-21.2%17.1%43.5%-8.5%-7.5%13.3%-27.7%-47.6%68.8%47.9%12.8%50.7%37.3%—
Dividend Yield4.2%4.2%—————————————————

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-46.0%

fácil

EPS terminal req.

$0.50

Spread vs growth

253.8%

5Y implied EPS CAGR

-28.3%

fácil

EPS terminal req.

$0.60

Spread vs growth

236.1%

10Y implied EPS CAGR

-11.2%

fácil

EPS terminal req.

$0.97

Spread vs growth

219.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -30.6%

Total return

-30.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-2.95 → 3.18

Residual

-34.8%

EPS growthn/d
Multiple reratingn/d
Dividend+4.2%
Residual / FX / buybacks / cross-term-34.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.